The 70,000-sq-ft production facilities house advanced capabilities for cell therapy manufacturing. In addition to cell processing equipment and manufacturing processes necessary to expand and re-engineer patient immune cells, the center will integrate advanced data and analytics approaches that enable a completely digital manufacturing process. This includes real-time data feedback and batch monitoring, as well as analytical capabilities that enable artificial intelligence and machine-learning applications to enable faster process improvements.